<DOC>
	<DOCNO>NCT01326364</DOCNO>
	<brief_summary>The purpose study first , determine whether baseline perfusion characteristic pancreatic cancer , characterize CT perfusion study , predict tumor response treatment stereotactic body radiotherapy ( SBRT ) . The second goal study determine whether baseline perfusion characteristic patient resectable pancreatic cancer correlate immunohistologic marker angiogenesis microvessel density vascular endothelial growth factor ( VEGF ) expression .</brief_summary>
	<brief_title>Prognostic Value Baseline Computed Tomography ( CT ) Perfusion Parameters Pancreatic Cancer Patients Undergoing Stereotactic Body Radiotherapy Surgical Resection</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>1. suspected and/or biopsyproven pancreatic adenocarcinoma , 2. referral Radiology pretreatment baseline pancreatic protocol CT. Exclusion criterion : 1 ) absolute contraindication intravenous iodinate contrast CT scan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>